Electronic clinical outcome assessment (eCOA) solutions market expected to reach $3.9 billion

CHICAGO, March 8, 2024 (Globe Newswire) — Electronic Clinical Outcome Assessment (eCOA) Solutions Market According to the latest report published by MarketsandMarkets™, sales are estimated to be worth $1.8 billion in 2024 and are expected to reach $3.9 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029 . The growth of this market is being driven by the reduction in costs and schedules associated with clinical trials. Furthermore, increasing acceptance of electronic clinical outcome assessment solutions in emerging markets and rise of mobile technology provides lucrative growth opportunities for electronic clinical outcome assessment (eCOA) solutions market participants throughout the forecast period 2024-2029. It is expected that

Download overview diagram: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=87857774

Electronic clinical outcome assessment (eCOA) solution market range:

Based on deployment model, the electronic clinical outcome assessment (eCOA) solutions market is segmented into on-premises models, web-hosted and cloud-based models, and hybrid models. The web-hosted and cloud-based model segment accounted for the largest share in 2023 due to its inherent advantages in terms of accessibility, scalability, and efficiency. Web-hosted and cloud-based deployment models provide a flexible and accessible infrastructure that enables seamless collaboration and data access from various locations, improving the overall efficiency of clinical trials. Researchers and medical professionals can easily collect and analyze real-time data, facilitating faster decision-making processes. A cloud-based approach eliminates the need for large on-site infrastructure, lowering costs and facilitating resource optimization. Additionally, the superiority of web and cloud-based eCOA solutions is also due to their ability to facilitate remote patient monitoring, an important aspect in the current era of decentralized clinical trials.

story continues

Based on application, the electronic clinical outcome assessment (eCOA) solutions market is segmented into clinical trials, observational studies and real-world evidence (RWE) generation, patient management and registration, and other applications. The clinical trials segment is further categorized into oncology, infectious diseases, neurology, metabolic diseases, cardiovascular diseases, immunology, rare and genetic diseases, mental health disorders, and other therapeutic areas. Among these subsegments, oncology accounted for the largest share of the electronic clinical outcome assessment (eCOA) solutions market in 2023 due to the unique challenges and complexities involved in oncology research. Oncology clinical trials often involve complex study protocols, intensive monitoring, and the need for accurate and real-time patient-reported outcomes (PROs). eCOA solutions play a pivotal role in addressing these challenges by providing a digital platform for efficient data collection and accurate assessment of treatment efficacy, side effects, and overall patient health. will be fulfilled.

By product type, the electronic clinical outcome assessment (eCOA) solutions market is segmented into electronic patient-reported outcomes (ePRO), electronic clinician-reported outcomes (eCLINRO), electronic observer-reported outcomes (eOBSRO), and electronic performance-reported outcomes (ePERFO). In 2023, the electronic observer reporting results (eOBSRO) segment is expected to register the highest growth within the forecast period. Observer-reported results (ObsROs) play an important role in collecting real-world evidence outside of controlled testing environments and informing post-market surveillance and regulatory decisions. Effective patient monitoring in decentralized clinical trials, improved data quality, and availability of a complete picture of patient experience and treatment response are some of the factors contributing to the growth of this field.

The electronic clinical outcome assessment (eCOA) solutions market is segmented into five major regional segments: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, Asia Pacific became the fastest growing segment in the eCOA solutions market due to a convergence of factors driving the adoption of advanced healthcare technologies in the region. The region is undergoing rapid modernization and digital transformation of healthcare, driven by increased investment in healthcare infrastructure, increased awareness of the importance of clinical research, and increasing prevalence of chronic diseases. Additionally, the region is becoming a hub for global clinical research, increasing the demand for efficient and reliable electronic data collection methods, such as eCOA solutions, to meet international standards and regulatory requirements.

Purchase the Electronic Clinical Outcome Assessment (eCOA) Solutions Industry Report (211-page PDF with insightful charts, tables, and figures). https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=87857774

The key players in the Electronic Clinical Outcome Assessment (eCOA) Solutions market covered in the report are:

• IQVIA (USA)

• Medidata (US)

• ICON Plc (Ireland)

• Signant Health (US)

• Clario (USA)

• Oracle Corporation (USA)

• Medable (USA)

• Merativ (USA)

• PAREXEL INTERNATIONAL (MA) CORPORATION (USA)

• Climedo Health GmbH (Germany)

• Hersentia (Belgium)

• Veeva Systems (USA)

• Assistec (USA)

• Curebase Inc. (USA)

• Caster (US)

• EvidentIQ Group GmbH (Germany)

• YPrime, LLC (USA)

• Clinical Ink (USA)

• Crinion (USA)

• Caientis (France)

• Transperfect (US)

• ObvioHealth USA, Inc. (USA)

• WCG Clinical (Germany)

• Clincapture (USA)

• Cloudbeads (USA)

• and above all

Request a free sample page: https://www.marketsandmarkets.com/requestsampleNew.asp?id=87857774

This study categorizes the Electronic Clinical Outcome Assessment (eCOA) Solutions market into the following segments and subsegments:

Electronic Clinical Outcome Assessment (eCOA) Solutions Market, By Component

Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Product Type

• Electronic Patient Report Results (ePRO)

• Electronic clinician-reported results (eCLINRO)

• Electronic Observer Report Results (eOBSRO)

• Electronic performance reporting results (ePERFO)

Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Deployment Model

Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Application Area

Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End User

• Pharmaceutical and biotech companies

• Contract research organization (CRO)

• medical technology companies

• Government agency

• academic research institute

• hospitals and healthcare providers

• consulting service company

Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Regions

• North America

• Europe

  • Germany

  • England

  • France

  • Italy

  • rest of europe

• Asia Pacific

  • Japan

  • China

  • India

  • Rest of Asia Pacific

• latin america

• middle east and africa

Get 10% free customization on this report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=87857774

Key market players:

• Electronic Clinical Outcome Assessment (eCOA) Solution Vendor

• Pharmaceutical and biotech companies

• Clinical Research Organization (CRO)

• Research and development (R&D) companies

• Business research and consulting service provider

• medical research institute

• Academic medical center/university/hospital

• regulatory body

• medical service provider

• venture capitalist

• advocacy group

• investors and financial institutions

Report purpose:

• Define, describe, and forecast the Electronic Clinical Outcome Assessment (eCOA) Solutions market by components, products, deployment models, applications, end users, and regions.

• To provide detailed information about the key drivers, constraints, opportunities, and challenges influencing the growth of the market

• To strategically analyze micromarkets 1 with respect to individual growth trends, prospects and contribution to the overall eCOA Solutions market.

• Analyze market opportunities for stakeholders and provide competitive landscape details for key players.

• We forecast the size of the eCOA solutions market in five major regions (and their respective countries): North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

• Delivering key industry insights including supply chain, regulation, patents and recession impact analysis.

• To profile the key players in the market and comprehensively analyze their core competencies2

• To track and analyze competitive developments such as product launches and upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, financings, and expansions of key players in the market.

• To benchmark the players within the market using company valuation matrix. It analyzes market players on various parameters within broad categories such as business strategies, market share, and product offerings.

Related reports:

Brain monitoring market

defibrillator market

clinical trial market

Clinical trial image market

e-clinical solutions market

Research insights: https://www.marketsandmarkets.com/ResearchInsight/ecoa-solutions-market.asp

Content source: https://www.marketsandmarkets.com/PressReleases/ecoa-solutions.asp

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com